Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Parogrelil (1 trial)
Intermittent Claudication (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Vascular Diseases (Phase 2)
Trials (1 total)
Trial APIs (1 total)